Cargando…

Serum miR-27a is a biomarker for the prognosis of non-small cell lung cancer patients receiving chemotherapy

BACKGROUND: Lung cancer has a high incidence and a 5-year survival rate of less than 15%. Non-small cell lung cancer (NSCLC) accounts for approximately 85% of lung cancer cases. Chemotherapy and immunotherapy are the most frequently used alternative treatments for patients with advanced-stage NSCLC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Erfu, Lin, Mingxin, Sun, Ziwei, Jin, Yuexinzi, Zhang, Shichang, Huang, Lei, Sun, Ruihong, Wang, Fang, Pan, Shiyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799153/ https://www.ncbi.nlm.nih.gov/pubmed/35116650 http://dx.doi.org/10.21037/tcr-20-3276

Ejemplares similares

Construction of Novel Prognostic Nomogram for Mucinous and Signet Ring Cell Colorectal Cancer Patients with a Survival Longer Than 5 Years
por: Xu, Juan, et al.
Publicado: (2022)

miR-638 is a new biomarker for outcome prediction of non-small cell lung cancer patients receiving chemotherapy
por: Wang, Fang, et al.
Publicado: (2015)

Significance of miR-27a and miR-31 in early diagnosis and prognosis of colorectal cancer
por: Cui, Qingjun
Publicado: (2019)

Follow-up value of serum AFP and aminotransferases in chronic hepatitis B progression
por: Yu, Mengyao, et al.
Publicado: (2023)

Host serum miR-223 is a potential new biomarker for Schistosoma japonicum infection and the response to chemotherapy
por: He, Xing, et al.
Publicado: (2013)

Correction of serum NSE reference intervals includes the unidentified hemolysis sample: 1‐year data analysis from healthcare individuals
por: Xie, Erfu, et al.
Publicado: (2019)

Elevated Serum miR-7, miR-9, miR-122, and miR-141 Are Noninvasive Biomarkers of Acute Pancreatitis
por: Lu, Pan, et al.
Publicado: (2017)

Exosome-Encapsulated miR-31, miR-192, and miR-375 Serve as Clinical Biomarkers of Gastric Cancer
por: He, Jing, et al.
Publicado: (2023)

Research on Correlations of miR-196a Expression with Progression and Prognosis of Cutaneous Squamous Cell Carcinoma
por: Zhang, Wei, et al.
Publicado: (2022)

Down-regulated miR-331–5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia
por: Feng, Dan-Dan, et al.
Publicado: (2011)

miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells
por: Salah, Zaidoun, et al.
Publicado: (2015)

Circulating miR-146b and miR-27b are efficient biomarkers for early diagnosis of Equidae osteoarthritis
por: Yassin, Aya M., et al.
Publicado: (2023)

microRNA, a Subtle Indicator of Human Cytomegalovirus against Host Immune Cells
por: Yu, Mengyao, et al.
Publicado: (2022)

Down Regulated Expression Levels of miR-27b and miR-451a as a Potential Biomarker for Triple Negative Breast Cancer Patients Undergoing TAC Chemotherapy
por: Abdul Aziz, Ahmad Aizat, et al.
Publicado: (2022)

MiR-205 as a promising biomarker in the diagnosis and prognosis of lung cancer
por: Li, Jing-Hua, et al.
Publicado: (2017)

Plasma miR-32 levels in non-small cell lung cancer patients receiving platinum-based chemotherapy can predict the effectiveness and prognosis of chemotherapy
por: Xu, Shuyuan, et al.
Publicado: (2019)

Exosomal miR-590-5p in Serum as a Biomarker for the Diagnosis and Prognosis of Gastric Cancer
por: Zheng, Guo-Dian, et al.
Publicado: (2021)

Serum miR-300 as a diagnostic and prognostic biomarker in osteosarcoma
por: Liu, Jian-Dong, et al.
Publicado: (2016)

Novel insights into IL-37: an anti-inflammatory cytokine with emerging roles in anti-cancer process
por: Gu, Min, et al.
Publicado: (2023)

Serum miR-22 may be a biomarker for papillary thyroid cancer
por: Wang, Deping, et al.
Publicado: (2019)

miR-125b and miR-100 Are Predictive Biomarkers of Response to Induction Chemotherapy in Osteosarcoma
por: Kubota, Daisuke, et al.
Publicado: (2016)

Serum exosomal miR-328, miR-575, miR-134 and miR-671-5p as potential biomarkers for the diagnosis of Kawasaki disease and the prediction of therapeutic outcomes of intravenous immunoglobulin therapy
por: Zhang, Xiaofei, et al.
Publicado: (2018)

MiR-27a: A Novel Biomarker and Potential Therapeutic Target in Tumors
por: Li, Xingwang, et al.
Publicado: (2019)

The Value of miR-296 and miR-517c in Evaluating the Prognosis of Patients with Glioma after Radiotherapy and Chemotherapy
por: Wang, Weiyu, et al.
Publicado: (2021)

Serum miR-626 and miR-5100 are Promising Prognosis Predictors for Oral Squamous Cell Carcinoma
por: Shi, Jianbo, et al.
Publicado: (2019)

Serum miR-214 Serves as a Biomarker for Prodromal Parkinson’s Disease
por: Li, Lanting, et al.
Publicado: (2021)

Downregulation of serum exosomal miR‐320d predicts poor prognosis in hepatocellular carcinoma
por: Li, Wenxiao, et al.
Publicado: (2020)

Serum SP70 is a sensitive predictor of chemotherapy response in patients with advanced nonsmall cell lung cancer
por: Liu, Jingping, et al.
Publicado: (2018)

Serum exosomal miR-122 as a potential diagnostic and prognostic biomarker of colorectal cancer with liver metastasis
por: Sun, Li, et al.
Publicado: (2020)

miR-16-5p, miR-103-3p, and miR-27b-3p as Early Peripheral Biomarkers of Fetal Growth Restriction
por: Tagliaferri, Salvatore, et al.
Publicado: (2021)

Cell-Free DNA Variables including Gene Mutations in CA15-3 Normal Breast Cancer Reflect Prognosis
por: Xu, Juan, et al.
Publicado: (2022)

Serum miR-146a and miR-150 as Potential New Biomarkers for Hip Fracture-Induced Acute Lung Injury
por: Gan, Li, et al.
Publicado: (2018)

Increased expression of miR-27 predicts poor prognosis and promotes tumorigenesis in human multiple myeloma
por: Che, Feifei, et al.
Publicado: (2019)

Serum miR-1228-3p and miR-181a-5p as Noninvasive Biomarkers for Non-Small Cell Lung Cancer Diagnosis and Prognosis
por: Xue, Wei-Xiao, et al.
Publicado: (2020)

Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma
por: Redova, Martina, et al.
Publicado: (2012)

Serum miR-1290 and miR-1246 as Potential Diagnostic Biomarkers of Human Pancreatic Cancer
por: Wei, Jia, et al.
Publicado: (2020)

Evaluation of serum miR‐216a and miR‐375 as biomarkers in dogs with acute pancreatitis
por: Lee, Dohee, et al.
Publicado: (2022)

Circulating miR-27b as a Biomarker of the Development and Progression of Carotid Artery Stenosis
por: Lu, Tingting, et al.
Publicado: (2021)

MiR-27a as a diagnostic biomarker and potential therapeutic target in systemic sclerosis
por: Bayati, Paria, et al.
Publicado: (2022)

Serum-based microRNA biomarkers for major depression: MiR-16, miR-135a, and miR-1202
por: Gheysarzadeh, Ali, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8hfk96ec3411omv5t40kiokqus